And Optasia Medical Ltd.

Related StoriesDePuy Synthes Spine launches new all-in-one pedicle screw program to greatly help simplify spinal surgeryWhole-genome sequencing identifies EN1 gene as determinant of bone mineral density, fractureCerapedics' i-FACTOR Peptide Enhanced Bone Graft gets FDA acceptance for make use of in cervical backbone surgeryCardea Technology evolves BoneStation, a web-based computer software that automates the review of VFA and X-Ray scans and the creation of bone density reviews. BoneStation facilitates the secure transmission of DXA scans and data from a bone densitometer to a central database where scans are immediately viewed from any computer with internet access. Through the scan review in BoneStation, your physician can add a patient’s bone fracture risk factors in to the patient’s overall evaluation and report.The CCS recommendations are based upon exhaustive evaluations of relevant published research undertaken by healthcare professionals identified across Canada and around the world for his or her expertise. The CCS guidelines are the gold regular in Canada and provide into query CDR’s scientific evaluation of Multaq’s clinical worth and the process behind its recommendation, said Hugh O’Neill, CEO and President of sanofi-aventis Canada. Unlike other countries, including the USA, U.K., France, Germany, Spain and Italy, that reimburse Multaq for atrial fibrillation sufferers, the drug is not available on the public formularies of any province in Canada.6 per cent versus 87.4 percent and 54.3 percent, respectively). These figures confirm the trend that the role of therapeutic innovation has been increasingly outweighed in the CDR critique process by provincial drug spending budget pressure.